EP3611505A4 - Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal - Google Patents

Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal Download PDF

Info

Publication number
EP3611505A4
EP3611505A4 EP18784065.7A EP18784065A EP3611505A4 EP 3611505 A4 EP3611505 A4 EP 3611505A4 EP 18784065 A EP18784065 A EP 18784065A EP 3611505 A4 EP3611505 A4 EP 3611505A4
Authority
EP
European Patent Office
Prior art keywords
rapid
accurate
self
detection signal
diagnostic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP18784065.7A
Other languages
German (de)
French (fr)
Other versions
EP3611505B1 (en
EP3611505A1 (en
Inventor
Jeewon Lee
Jeong-Hyeok KWON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellemedy Co Ltd
Original Assignee
Cellemedy Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellemedy Co Ltd filed Critical Cellemedy Co Ltd
Publication of EP3611505A1 publication Critical patent/EP3611505A1/en
Publication of EP3611505A4 publication Critical patent/EP3611505A4/en
Application granted granted Critical
Publication of EP3611505B1 publication Critical patent/EP3611505B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP18784065.7A 2017-04-13 2018-04-13 Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal Active EP3611505B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170047841A KR101970327B1 (en) 2017-04-13 2017-04-13 A Method for Accurate, Rapid, and Convenient One-Step-Diagnosis of Disease Based on Signal Self-Enhancement
PCT/KR2018/004313 WO2018190664A1 (en) 2017-04-13 2018-04-13 Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal

Publications (3)

Publication Number Publication Date
EP3611505A1 EP3611505A1 (en) 2020-02-19
EP3611505A4 true EP3611505A4 (en) 2020-12-23
EP3611505B1 EP3611505B1 (en) 2022-06-08

Family

ID=63792692

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18784065.7A Active EP3611505B1 (en) 2017-04-13 2018-04-13 Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal

Country Status (6)

Country Link
US (1) US11668712B2 (en)
EP (1) EP3611505B1 (en)
JP (1) JP6989179B2 (en)
KR (1) KR101970327B1 (en)
CN (1) CN110573879B (en)
WO (1) WO2018190664A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102293984B1 (en) * 2020-02-13 2021-08-26 셀리게인 주식회사 3-dimensional immunodiagnostics based on detection signal control
WO2022234869A1 (en) * 2021-05-03 2022-11-10 셀리게인 주식회사 Accurate three-dimensional immunodiagnostics based on detection signal control
KR102485429B1 (en) * 2022-09-30 2023-01-09 주식회사 학메디칼 Composition for diagnosis of sars-cov-2 infection and diagnostic kit using thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU601273B2 (en) 1987-03-20 1990-09-06 Creative Biomolecules, Inc. Leader sequences for the production of recombinant proteins
EP0305500B1 (en) 1987-03-20 1994-11-09 Creative Biomolecules, Inc. Process for the purification of recombinant polypeptides
DE3856559T2 (en) 1987-05-21 2004-04-29 Micromet Ag Multifunctional proteins with predetermined objectives
KR0151305B1 (en) 1995-12-21 1998-10-15 김태구 Bumper molding presser for a car
MXPA04008753A (en) * 2002-03-12 2004-12-06 Ark Therapeutics Ltd Engineered baculoviruses and their use.
EP1704405A1 (en) * 2003-12-31 2006-09-27 The President and Fellows of Harvard College Assay device and method
US7588624B2 (en) * 2005-03-10 2009-09-15 Northwestern University Method of producing gold nanoprisms
US20080292545A1 (en) * 2007-04-04 2008-11-27 Yuehe Lin Functionalized Encoded Apoferritin Nanoparticles and Processes for Making and Using Same
EP2156185B1 (en) * 2007-06-01 2013-08-14 Atonomics A/S Bio surface acoustic wave (saw) resonator amplification with nanoparticles for detection of a target analyte
US8088392B2 (en) * 2007-06-18 2012-01-03 Yunxu Cao Capsid proteins and uses therefore
CN101408496B (en) * 2008-11-18 2011-08-17 中国检验检疫科学研究院 Method for performing biological mark detection by atomic force microscope
KR101027036B1 (en) * 2009-05-28 2011-04-11 주식회사 인포피아 Method for amplification of signal in lateral flow assay by reduction of gold ion and lateral flow assay device using the method
GB2470939A (en) * 2009-06-10 2010-12-15 Dna Supernova Ltd Signal amplification microspheres
US8969619B2 (en) * 2009-07-21 2015-03-03 Ge Healthcare As Synthesis of iodixanol in propyleneglycol
KR20110090347A (en) 2010-02-03 2011-08-10 고려대학교 산학협력단 A chimeric protein, a preparation method thereof, a nanosenser fixed with the same and an application thereof
US9925592B2 (en) * 2010-09-24 2018-03-27 Nanyang Technological University Method for fabricating a gold nanoparticle
US9465003B2 (en) * 2010-12-16 2016-10-11 Korea Research Institute Of Bioscience And Biotechnology Membrane phase electrode using printing and bio-molecule detection using same
KR101836921B1 (en) * 2013-05-10 2018-03-12 고려대학교 산학협력단 Recombinant self-assembling protein comprising a target-specfic peptide and use thereof
JP6099108B2 (en) * 2013-05-30 2017-03-29 公立大学法人大阪府立大学 Apparatus and method for detecting a substance to be detected
KR101495665B1 (en) 2014-05-09 2015-02-26 한국생명공학연구원 Method for magnetic transfer multi-fluorescence immunoassay
KR20160051393A (en) 2014-11-03 2016-05-11 고려대학교 산학협력단 Protein nanoparticle linked with multiple disease specific marker epitope and ultra-sensitive method for detecting disease specific marker using it
CN104726560B (en) * 2015-02-11 2015-12-02 青岛大学 A kind of colorimetry detecting zymoplasm
KR20160117688A (en) * 2015-03-30 2016-10-11 한국전자통신연구원 A method for detecting biomaterials
JP6623406B2 (en) * 2015-08-11 2019-12-25 池田食研株式会社 Binder
KR20170023589A (en) * 2015-08-24 2017-03-06 고려대학교 산학협력단 A Method and Kit for simultaneously detecting multiple diseases based on 3D protein nanoparticle probes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J-H. KWON ET AL: "Signal self-enhancement by coordinated assembly of gold nanoparticles enables accurate one-step-immunoassays", NANOSCALE, vol. 9, no. 42, 28 September 2017 (2017-09-28), United Kingdom, pages 16476 - 16484, XP055749733, ISSN: 2040-3364, DOI: 10.1039/C7NR03453A *

Also Published As

Publication number Publication date
CN110573879B (en) 2023-05-16
JP6989179B2 (en) 2022-01-05
EP3611505B1 (en) 2022-06-08
CN110573879A (en) 2019-12-13
JP2020516918A (en) 2020-06-11
KR20180115480A (en) 2018-10-23
WO2018190664A1 (en) 2018-10-18
KR101970327B1 (en) 2019-04-18
US20200124599A1 (en) 2020-04-23
EP3611505A1 (en) 2020-02-19
US11668712B2 (en) 2023-06-06

Similar Documents

Publication Publication Date Title
EP3644220A4 (en) Detection of electrocardiogram signal
IL289907A (en) Methods and systems for analyte detection and analysis
EP3171765A4 (en) Collection and analysis of data for diagnostic purposes
EP3344261A4 (en) Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
EP3335036A4 (en) Detection and monitoring of changes in metallic structures using multimode acoustic signals
SG10201702280YA (en) System and method for the rapid measurement of the visual contrast sensitivity function
EP3270354A4 (en) Living body detection device, living body detection method, and recording medium
EP3523639A4 (en) Detection reagents and electrode arrangements for multi-analyte diagnostic test elements, as well as methods of using the same
EP3364670A4 (en) Signal strength measurement method and device
EP3662816A4 (en) Biometric signal-measuring apparatus equipped with trap unit for measuring biometric signal of micro-animal, and method for measuring biometric signal of micro-animal using same
IL254687A0 (en) Biosensor system for the rapid detection of analytes
EP3449819A4 (en) Pulse wave detection device, biological information measurement device, pulse wave detection method, and pulse wave detection program
EP3453320A4 (en) Pressure pulse wave sensor, pulse wave detection device, and biological information measurement device
EP3151094A4 (en) Indicator detection device and signal processing method thereof
EP3373494A4 (en) Method of transmitting sounding reference signal and device utilizing same
EP3292395A4 (en) Methods and systems for the detection of analytes
EP3443894A4 (en) Pulse wave detection device, biological information measuring device, wearing auxiliary member of pulse wave detection device
TWI562758B (en) Physiological signal measuring system and method thereof
EP3611505A4 (en) Accurate, rapid and convenient single-step disease diagnostic method using self-amplification principle of detection signal
EP3355606A4 (en) Method and device for detecting signal strength
EP3258404A4 (en) Method and system for health condition analysis on the basis of elasticity detection device
EP3430990A4 (en) Pulse wave detection device and biological information measurement device
EP3409208A4 (en) Ultrasound probe and ultrasound diagnosis system including same
EP3370074A4 (en) Method for detecting background noise of sensor, and device thereof
EP3324848A4 (en) Sensor, sensor pad and sensor array for detecting infrasonic acoustic signals

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201120

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/543 20060101AFI20201116BHEP

Ipc: G01N 33/569 20060101ALI20201116BHEP

Ipc: G01N 33/52 20060101ALI20201116BHEP

Ipc: G01N 33/553 20060101ALI20201116BHEP

Ipc: G01N 33/536 20060101ALI20201116BHEP

Ipc: G01N 33/58 20060101ALI20201116BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210714

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220211

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1497273

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220615

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018036557

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220908

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220909

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220908

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1497273

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221010

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20221008

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602018036557

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

26N No opposition filed

Effective date: 20230310

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230420

Year of fee payment: 6

Ref country code: FR

Payment date: 20230424

Year of fee payment: 6

Ref country code: DE

Payment date: 20230420

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230417

Year of fee payment: 6

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230413

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220608

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230413

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230413